Inventor

CAMBIER JOHN C

US7 patents

⚠️ This page may combine multiple inventors who share the name “CAMBIER JOHN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NAT JEWISH HEALTH

3 patents

US10760055B2Sep 1, 2020

Conditionally immortalized long-term stem cells and methods of making and using such cells

NAT JEWISH HEALTH8 citations82

US7825224B2Nov 2, 2010

Product and method for treatment of conditions associated with receptor-desensitization

NAT JEWISH HEALTH9 citations79

US9796961B2Oct 24, 2017

Conditionally immortalized long-term stem cells and methods of making and using such cells

NAT JEWISH HEALTH0 citations50

CAMBIER JOHN C

2 patents

US9150831B2Oct 6, 2015

Conditionally immortalized long-term stem cells and methods of making and using such cells

CAMBIER JOHN C19 citations89

US8883507B2Nov 11, 2014

Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells

CAMBIER JOHN C1 citations59

NAT JEWISH MEDICAL & RES CT

1 patent

US6503509B1Jan 7, 2003

Method for receptor desensitization

NAT JEWISH MEDICAL & RES CT14 citations78

Nepenthe Bioscience LLC

1 patent

US11078276B2Aug 3, 2021

Anti-CD79 antibodies and their uses

Nepenthe Bioscience LLC1 citations50